The explanation for this observation is unclear, but may involve a more vigorous pre-MTZ mucosal immune response helping to clear BV-associated bacteria, presence of inflammatory but MTZ- or LBP-responsive bacteria in some participants at baseline, or other mechanisms. The gene discussed is LBP; the disease is bacterial vaginosis.